CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Bayer banks €3bn in Apollo contraceptives division deal

contraceptivesPositive
AI Analysis

Summary

Bayer has agreed to divest its Apollo contraceptives division for €3 billion. This deal follows Bayer's May 2026 acquisition of Perfuse Therapeutics.

Importance:7/10
Sentiment:
0.60
M&Adivestiturecontraceptivesdealmaking
Related Companies

Read the original article

Published by Pharmaceutical Technology on July 10, 2026 1:11 PM

Read Original